1. Home
  2. PODD vs WY Comparison

PODD vs WY Comparison

Compare PODD & WY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PODD
  • WY
  • Stock Information
  • Founded
  • PODD 2000
  • WY 1900
  • Country
  • PODD United States
  • WY United States
  • Employees
  • PODD N/A
  • WY N/A
  • Industry
  • PODD Medical/Dental Instruments
  • WY Real Estate Investment Trusts
  • Sector
  • PODD Health Care
  • WY Real Estate
  • Exchange
  • PODD Nasdaq
  • WY Nasdaq
  • Market Cap
  • PODD 21.5B
  • WY 18.7B
  • IPO Year
  • PODD 2007
  • WY N/A
  • Fundamental
  • Price
  • PODD $278.58
  • WY $25.71
  • Analyst Decision
  • PODD Strong Buy
  • WY Buy
  • Analyst Count
  • PODD 19
  • WY 8
  • Target Price
  • PODD $320.11
  • WY $32.88
  • AVG Volume (30 Days)
  • PODD 504.7K
  • WY 4.8M
  • Earning Date
  • PODD 08-07-2025
  • WY 07-24-2025
  • Dividend Yield
  • PODD N/A
  • WY 3.26%
  • EPS Growth
  • PODD 67.46
  • WY N/A
  • EPS
  • PODD 5.55
  • WY 0.38
  • Revenue
  • PODD $2,198,900,000.00
  • WY $7,036,000,000.00
  • Revenue This Year
  • PODD $24.54
  • WY $2.04
  • Revenue Next Year
  • PODD $17.48
  • WY $5.94
  • P/E Ratio
  • PODD $50.63
  • WY $67.98
  • Revenue Growth
  • PODD 23.48
  • WY N/A
  • 52 Week Low
  • PODD $173.00
  • WY $24.10
  • 52 Week High
  • PODD $329.33
  • WY $34.03
  • Technical
  • Relative Strength Index (RSI)
  • PODD 38.53
  • WY 49.78
  • Support Level
  • PODD $282.75
  • WY $24.72
  • Resistance Level
  • PODD $290.25
  • WY $26.35
  • Average True Range (ATR)
  • PODD 5.49
  • WY 0.66
  • MACD
  • PODD 0.05
  • WY -0.02
  • Stochastic Oscillator
  • PODD 2.88
  • WY 55.50

About PODD Insulet Corporation

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetics are using it worldwide.

About WY Weyerhaeuser Company

Weyerhaeuser ranks among the world's largest forest product companies. Following the 2016 sale of its pulp business to International Paper, Weyerhaeuser operates three business segments: timberlands, wood products, and real estate. Weyerhaeuser is structured as a real estate investment trust and is not required to pay federal income taxes on earnings generated by timber harvest activities. Earnings from its wood products segment are subject to federal income tax. Weyerhaeuser acquired fellow timber REIT Plum Creek in 2016.

Share on Social Networks: